New data for Roche’s Ocrevus show benefit in disability progression and cognitive decline in secondary progressive and primary progressive multiple sclerosis Read more
GE Healthcare announces first patient dosed in phase-III clinical trial for new dopamine transporter imaging radiopharma Read more
CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma Read more
Pfizer announces positive results for phase-III trial of Etrasimod in Ulcerative Colitis patients Read more